Publication | Closed Access

Lot-to-lot consistency of live attenuated SA 14-14-2 Japanese encephalitis vaccine manufactured in a good manufacturing practice facility and non-inferiority with respect to an earlier product

VaccinationLot-to-lot ConsistencyVaccine DevelopmentEgg-based Vaccine ProductionEarlier ProductPathogenesisImmunologyInfection ControlVaccine DesignMedicineVaccine ResearchCovid-19